Advertisement
Screener

Regenicin, Inc. Quick Ratio

Regenicin, Inc. Quick Ratio

  • Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2023-03-31..

Quick ratio

Overview →

Financial period ending 2023-03-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Quick ratio · latest quarter(m)Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2023-03-31.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Cash, securities and trade receivables(m)Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current
Current obligations18.07M USDLiabilities, Current
Cash and equivalents(m)Cash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables(m)Accounts Receivable, after Allowance for Credit Loss, Current
Inventory · excluded from quick assets(m)

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCash, securities and trade receivables (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory · excluded from quick assets (USD)Quick ratio
2023-03-31(m)$18.07M(m)(m)(m)(m)(m)
2022-12-31(m)$17.67M(m)(m)(m)(m)(m)
2022-09-30(m)$5.61M(m)(m)(m)(m)(m)
2022-06-30(m)$5.44M(m)(m)(m)(m)(m)
2022-03-31(m)$5.28M(m)(m)(m)(m)(m)
2021-12-31(m)$5.12M(m)(m)(m)(m)(m)
2021-09-30(m)$5.61M(m)(m)(m)(m)(m)
2021-06-30(m)$4.85M(m)(m)(m)(m)(m)
2021-03-31(m)$4.68M$1.33K(m)(m)(m)(m)
2020-12-31(m)$4.45M$1.37K(m)(m)(m)(m)
2020-09-30(m)(m)$1.37K(m)(m)(m)(m)
2020-06-30(m)$4.29M$1.40K(m)(m)(m)(m)
2020-03-31(m)$4.12M$1.48K(m)(m)(m)(m)
2019-12-31(m)$4.29M$1.37K(m)(m)(m)(m)
2019-09-30(m)$3.73M$815.00(m)(m)(m)(m)
2019-06-30(m)$3.59M$1.71K(m)(m)(m)(m)
2019-03-31(m)$3.43M$1.60K(m)(m)(m)(m)
2018-12-31(m)$3.26M$1.83K(m)(m)(m)(m)
2018-09-30(m)$3.06M$2.70K(m)(m)(m)(m)
2018-06-30(m)$3.09M$1.31K(m)(m)(m)(m)
2018-03-31(m)$2.91M$2.11K(m)(m)(m)(m)
2017-12-31(m)$2.70M$7.32K(m)(m)(m)(m)
2017-09-30(m)$2.53M$19.20K(m)(m)(m)(m)
2017-06-30(m)$2.53M$19.20K(m)(m)(m)(m)
2017-03-31(m)$2.21M$40.07K(m)(m)(m)(m)
2016-12-31(m)$1.94M$50.39K(m)(m)(m)(m)
2016-09-30(m)$1.83M$218.85K(m)(m)(m)(m)
2016-06-30(m)$2.48M$343.43K(m)(m)(m)(m)
2016-03-31(m)$2.40M$586.06K(m)(m)(m)(m)
2015-12-31(m)$2.32M$794.85K(m)(m)(m)(m)
2015-09-30(m)$1.93M$1.06M(m)(m)(m)(m)
2015-06-30(m)$2.26M$1.43M(m)(m)(m)(m)
2015-03-31(m)$2.49M$2.12M(m)(m)(m)(m)
2014-12-31(m)$3.39M$273.72K(m)$450.00K(m)(m)
2014-09-30(m)$4.40M$492.00(m)(m)(m)(m)
2014-06-30(m)$4.37M(m)(m)(m)(m)(m)
2014-03-31(m)$4.19M(m)(m)(m)(m)(m)
2013-12-31(m)$4.00M(m)(m)(m)(m)(m)
2013-09-30(m)$4.24M$22.50K(m)(m)(m)(m)
2013-06-30(m)$3.36M(m)(m)(m)(m)(m)
2013-03-31(m)$3.58M(m)(m)(m)(m)(m)
2012-12-31(m)$3.56M(m)(m)(m)(m)(m)
2012-09-30(m)$3.55M(m)(m)(m)(m)(m)
2012-06-30(m)$3.33M(m)(m)(m)(m)(m)
2012-03-31(m)$2.83M(m)(m)(m)(m)(m)
2011-12-31(m)$2.25M(m)(m)(m)(m)(m)
2011-09-30(m)$1.47M(m)(m)(m)(m)(m)
2011-06-30(m)$1.02M(m)(m)(m)(m)(m)
2010-09-30(m)$829.54K(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.